GALVmed’s Market Development & Access (MD&A) department in South Asia has been working with the Jeevika Trust recently to deliver training in goat rearing in Bihar, India. The trust was aware of GALVmed’s work and its expertise in animal health and management. It approached the organisation through the Aga Khan Foundation (AKF) to train their officials on goat health […]

        Release date: 24 May 2017 EDINBURGH, UK, May 24, 2017 – Small ruminant experts attending this month’s International Sheep Veterinary Congress in Harrogate are being encouraged to enter a US $30 million prize competition to develop a brucellosis vaccine to improve the livelihoods of smallholder farmers in developing countries. The Brucellosis […]

(Johannesburg, 11 May 2017) In a globalising world where clusters of countries increasingly face the same challenges and seek closer cooperation to deal with these issues together, great gains can be made by harmonising approaches to problem solving and avoiding duplication of efforts among countries in the same region. One such area is the registration of […]

LEUVEN, Belgium, May 17th, 2017 — ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce a collaboration with GALVmed. Under the collaboration, ViroVet will extend its vaccine pipeline to include novel vaccines for small ruminants. Since its capital increase in December […]

(15th February 2015) GALVmed recently held a workshop Nairobi (19-20 January 2017) to discuss ongoing research to improve the East Coast Fever (ECF) vaccine. The vaccine, commonly known as Infection and Treatment Method (ITM)  was developed in mid-70s and since then new tools have been developed   to characterise the vaccine strains/stocks and provide new knowledge […]

As part of GALVmed’s regulatory harmonisation efforts, a new document was developed to provide a summarised overview of the country requirements and procedures needed to register veterinary products in 30 African and South Asian countries. Registering veterinary medicines through the current processes is cumbersome, often unpredictable and time consuming. The new report is a resource […]

GALVmed and AgResults are delighted to announce the launch of the Brucellosis Vaccine Initiative, a US $30 million prize competition aimed at incentivising animal health companies to develop a vaccine against brucellosis to be used mainly in developing countries. The prize – one of the largest of its kind – is funded by AgResults, a […]

World Animal Vaccination Day promotes the importance of vaccination in all animals. More than 100 animal diseases can be prevented through vaccination, helping to protect many species including dogs, cats, cattle, swine, poultry, horses, sheep, exotic pets, fish and wild animals. The Global Alliance for Livestock Veterinary Medicines (GALVmed) focuses on 12 neglected livestock diseases […]

A recent Guardian article has showcased the research, technical innovation and knowledge-sharing partnership between the UK Government and the Bill & Melinda Gates Foundation that is aimed at transforming the lives of the world’s poorest people. The Gates Foundation invests more than £350m a year in global health research and has contributed over £370m in […]

GALVmed is collaborating with commercial animal health company, Hester Biosciences Limited and the Jharkhand State Livelihood Promotion Society (JSLPS) to extend poultry and small ruminant vaccination and health care services in remote areas of Jharkhand, India. This vaccine delivery collaboration is a first of its kind for a public-private partnership in India. Under this agreement, […]